Abstract
A total of 16 drugs developed in Japan are currently under Phase I or II trials. This article reviews results of some studies of these drugs. Studies included in the article are of SM-5887, MX-2, DWA2114R, and CPT-11.
MeSH terms
-
Animals
-
Antibiotics, Antineoplastic / therapeutic use
-
Antineoplastic Agents / therapeutic use*
-
Carboplatin / analogs & derivatives
-
Carboplatin / therapeutic use
-
Cisplatin / analogs & derivatives
-
Clinical Trials, Phase I as Topic
-
Clinical Trials, Phase II as Topic
-
Humans
-
Japan
-
Organoplatinum Compounds / therapeutic use
Substances
-
Antibiotics, Antineoplastic
-
Antineoplastic Agents
-
Organoplatinum Compounds
-
DWA 2114
-
nedaplatin
-
Carboplatin
-
Cisplatin